Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

 We refer to our earlier communication dated 28th June, 2022 regarding closure of trading window (for the purpose of financial results for the quarter ended 30th June, 2022) starting from 29th June, 2022 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter ended 30th June, 2022 are communicated to the Stock Exchanges. The Financial Results of the Company for the quarter ended 30th June, 2022 having been communicated to the Stock Exchanges, today i.e. 05th August, 2022, the trading window shall open on 08th August, 2022.
05-08-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY23 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same.
05-08-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 (LODR)- Cut-Off Date For Postal Ballot

 This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, the Board of Directors of the Company at its meeting held today i.e. 05th August, 2022 have decided to seek approval of the shareholders by way of Postal Ballot through remote e-voting for appointment of Mr. Sujjain Talwar (DIN: 01756539) as an Independent Director of the Company to hold office for a period of five (5) consecutive years w.e.f. 05th August, 2022 to 04th August, 2027. The Company has fixed Friday, 19th August, 2022 as cut-off date for ascertaining the eligibility of shareholders for dispatch of Postal Ballot Notice and remote voting through electronic means. Kindly take note of the same.
05-08-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Directorate

 The Board of Directors at its meeting held today, i.e. 05th August, 2022, based on the recommendation of Nomination & Remuneration Committee and subject to approval of shareholders, approved the appointment of Mr. Sujjain Talwar (DIN: 01756539) as an Additional Director, designated as an Independent Director on the Board of Directors of the Company for a period of five (5) consecutive years with effect from 05th August, 2022 upto 04th August, 2027. Necessary particulars in relation to the said appointment, are included in Annexure I. We also confirm that Mr. Sujjain Talwar is not debarred from holding office of director by virtue of any SEBI order or any other such authority. Kindly take the same on your records.
05-08-2022
Bigul

Alkem Laboratories Ltd - 539523 - Results- Financial Results For Quarter Ended June 30, 2022

 In continuation of our letter dated 25th July, 2022 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company, at its meeting held today, i.e. 05th August, 2022 have inter alia approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2022. A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Listing Regulations, is enclosed herewith. The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.20 P.M. KIndly take the same on record.
05-08-2022
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Dated 05/08/2022

 The Board of Directors of the Company, at its meeting held today, i.e. 05.08.2022 have inter alia: 1. approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30.06 2022. A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Reg 33 of the Listing Regulations, is enclosed herewith. 2. based on recommendation of Nomination and Remuneration Committee and subject to approval of shareholders, approved the appointment of Mr. Sujjain Talwar (DIN: 01756539) as an Additional Director designated as an Independent Director on the Board of Directors of the Company for a period of five (5) consecutive years with effect from 05.08.2022 to 04.08.2027. The meeting of the Board of Directors of the Company commenced at 11.00 A.M and concluded at 1.20 P.M. Kindly take the same on record.
05-08-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q1FY23 financial results will be held on Friday, 05th August, 2022 at 04.00 pm. Please find attached herewith the conference call details. Kindly take note of the same.
26-07-2022
Bigul

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of Alkem Laboratories Limited

 Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30th June, 2022. Kindly take note of the same.
25-07-2022
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"), please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Mumbai Lakshadweep (Marathi) informing about completion of dispatch of Notice of the 48th AGM alongwith Annual Report for the financial year 2021-22 through electronic mode and availability of e-voting facility available to the shareholders. The same is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on record.
12-07-2022

Indian pharma industry may rebound to 8-11% growth rate, says Alkem

 Alkem Laboratories expects the Indian pharmaceutical industry to rebound to 8-11 per cent growth rate with normalcy in activities as the pandemic eases out
11-07-2022
Next Page
Close

Let's Open Free Demat Account